Etomidate is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Civica, Inc.. The primary component is Etomidate.
| Product ID | 72572-160_9ff746d0-b7b4-4917-b2a8-1d6c5b4288e1 |
| NDC | 72572-160 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Etomidate |
| Generic Name | Etomidate |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-03-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA202354 |
| Labeler Name | Civica, Inc. |
| Substance Name | ETOMIDATE |
| Active Ingredient Strength | 2 mg/mL |
| Pharm Classes | General Anesthesia [PE], General Anesthetic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9310 | Etomidate | Etomidate |
| 0143-9311 | Etomidate | Etomidate |
| 0143-9506 | Etomidate | Etomidate |
| 0143-9507 | Etomidate | Etomidate |
| 23155-160 | Etomidate | Etomidate |
| 23155-522 | Etomidate | Etomidate |
| 25021-674 | etomidate | etomidate |
| 51662-1485 | ETOMIDATE | ETOMIDATE |
| 51662-1542 | ETOMIDATE | ETOMIDATE |
| 55150-221 | ETOMIDATE | ETOMIDATE |
| 55150-222 | ETOMIDATE | ETOMIDATE |
| 65145-127 | Etomidate | Etomidate |
| 65145-128 | Etomidate | Etomidate |
| 65219-445 | Etomidate | Etomidate |
| 65219-447 | Etomidate | Etomidate |
| 65841-818 | etomidate | etomidate |
| 67457-902 | Etomidate | Etomidate |
| 67457-903 | Etomidate | Etomidate |
| 68083-234 | Etomidate | Etomidate Injection |
| 68083-235 | Etomidate | Etomidate Injection |
| 68382-545 | etomidate | etomidate |
| 70518-1003 | Etomidate | Etomidate |
| 70860-652 | Etomidate | Etomidate |
| 72266-146 | Etomidate | Etomidate |
| 72266-147 | Etomidate | Etomidate |
| 0404-9811 | Amidate | Etomidate |
| 0409-6695 | Amidate | ETOMIDATE |
| 0409-8060 | Amidate | Etomidate |
| 52584-695 | Amidate | Etomidate |